Get started
Award

2021m3a9i2080498

Funded outputs count: 9
Funder award ID: 2021M3A9I2080498
OpenAlex ID: G7679108910
Cytomegalovirus reactivation in the lower respiratory tract as an independent risk factor for mortality in critically Ill patients
2025 · Joong-Yub Kim, Chan Mi Lee, et al. · Critical Care · 6
PDF
Impact of Rituximab on COVID-19 in Immunocompromised Patients: A Nationwide Cohort Study in Korea
2025 · Chan Mi Lee, Suhyun Kim, et al. · Open Forum Infectious Diseases · 3
PDF
Risk of nosocomial coronavirus disease 2019: comparison between single- and multiple-occupancy rooms
2024 · Hyeon Jae Jo, Pyoeng Gyun Choe, et al. · Antimicrobial Resistance and Infection Control · 12
PDF
Impact of T-Cell Engagers on COVID-19–Related Mortality in B-Cell Lymphoma Patients Receiving B-Cell Depleting Therapy
2023 · Chan Mi Lee, Pyoeng Gyun Choe, et al. · Cancer Research and Treatment · 9
PDF
Low humoral and cellular immune responses early after breakthrough infection may contribute to severe COVID-19
2023 · Chan Mi Lee, Pyoeng Gyun Choe, et al. · Frontiers in Immunology · 4
PDF
Effect of Wearing Personal Protective Equipment (PPE) for COVID-19 Treatment on Blood Culture Contamination: Implication for Optimal PPE Strategies
2023 · Jae Hyeon Park, Taek Soo Kim, et al. · Journal of Korean Medical Science · 2
PDF
Prospective longitudinal analysis of antibody response after standard and booster doses of SARS-COV2 vaccination in patients with early breast cancer
2022 · Jinyong Kim, Jiyun Jeong, et al. · Frontiers in Immunology · 4
PDF
Evaluation of Seropositivity After Standard Doses of Vaccination Against SARS-CoV-2 in Patients With Early Breast Cancer Receiving Adjuvant Treatment
2022 · Jinyong Kim, Euijin Chang, et al. · The Oncologist · 3
PDF
Persistence of Neutralizing Antibody Response up to 1 Year After Asymptomatic or Symptomatic SARS-CoV-2 Infection
2021 · Pyoeng Gyun Choe, Chang Kyung Kang, et al. · The Journal of Infectious Diseases · 27
PDF
Year
Topic